학술논문
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
Document Type
Article
Author
Source
In The Lancet 2-8 August 2014 384(9941):403-413
Subject
Language
ISSN
0140-6736